BAFNAPHUpdated 1 Sept 2026, 16:23

Bafna Pharmaceuticals Ltd

BAFNAPHUpdated 1 Sept 2026, 16:23

Market Cap

₹745Cr.

Current Price

₹315

High / Low

₹318/94.8

Stock P/E

95.6

ROE12.3%

ROCE11.9%

Book Value₹40.6

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1981, Bafna PharmaceuticalsLtd manufactures finished pharmaceutical formulations[1]

Quarterly results

Last reported quarters₹ Cr.

Annual statement₹ Cr.

As of Jun 2026%

Ownership over time%

Assets & liabilities₹ Cr.

Operating, investing & financing₹ Cr.

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	303	291	302	195	208	52	49	63	130	109	101	106
Inventory Days	66	92	118	102	122	208	154	185	129	125	127	129
Days Payable	149	169	164	265	517	229	107	113	165	149	140	139
Cash Conversion Cycle	220	214	255	31	-188	31	96	135	94	84	88	96
Working Capital Days	56	125	-36	-108	-210	89	121	123	104	92	74	74
ROCE %	-13%	-0%	-6%	-35%	-21%	-3%	10%	11%	16%	9%	8%	12%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 16:23